Immunology is saying goodbye to Orencia and everyone who has supported it and hello to anyone and everyone with derm experience. Lied to by Tina, Orencia salesforce should have a great "rest of the year" waiting for the ax to fall in January.
-
Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page
Goodbye and thanks Orencia folks
- Thread starter anonymous
- Start date
-
- Tags
- None
good. I have so much banked vacation and time with the company, I won’t have to do shit for years. Pay up suckers!
It just happens. In the not so distant past, the company had a hospital division, a diabetes division, a neuroscience division, and probably the longest lasting of them that is now extinct is the virology division.
Good summary. Just when neuro, virology and endocrinology get really, really hot - BMS is again looking through the rear view mirror.
Does the little Italian know what he is doing? Wall Street says no based on our stock over the last 2 years.
Later chumps!
Tina is the Witch of Narnia. I’m positive when her temp is sub zero. Which explains her emotional range. 